Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects.
about
Stimulation of incretin secreting cellsRoux-en-Y gastric bypass: effects on feeding behavior and underlying mechanismsChanges in neurohormonal gut peptides following bariatric surgery.Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels.Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric bandingCould the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a reviewChanges in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery.Weight Loss as a Cure for Type 2 Diabetes? Fact or Fantasy.Mechanisms responsible for excess weight loss after bariatric surgeryGastrointestinal hormones and bariatric surgery-induced weight lossRole of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery.GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgeryEndocrine and metabolic response to gastric bypass.Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.The role of hormonal factors in weight loss and recidivism after bariatric surgery.Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery.Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure.Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.Patterns of Weight Loss Response Following Gastric Bypass and Sleeve Gastrectomy.Weight Regain After Gastric Bypass: Influence of Gut Hormones.Pancreatic polypeptide meal response may predict gastric band-induced weight loss.Evening chronotype associates with obesity in severely obese subjects: interaction with CLOCK 3111T/C.Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.
P2860
Q26765259-AEFF72D3-5FCA-4FF7-938C-AA0C673E1E9AQ27000617-02EE171C-0261-4D3C-821B-23BBBC53208FQ30391329-1C89A84E-3B85-4C5B-8126-F7D5213039C2Q33752066-240D6D36-0578-4DCD-B972-636C70112536Q33789529-8B8CBBAB-DE3B-4CBF-BCEB-BE68C7A8EAE9Q33879265-1D29114A-A895-4FB9-A85C-0A1713368669Q34589770-3D4943F5-1B17-474D-85B2-6309793EC2BFQ34615425-CEDF9C13-E5D3-4FE9-AD08-5CFD6DA35AA2Q34824005-1033F547-3847-40A8-A519-58D141858056Q34824270-2DFB78CB-766A-4B34-96F5-EA1FB18F2C46Q35132986-D2448FEB-DC33-4EA4-A9D6-D735F81A9C95Q35529693-C2B6227B-CA03-4B11-A13C-3B59786616ADQ35581251-66FF81D9-6604-4C89-BE58-563BA8A40772Q35963032-4E9749DF-9E15-4304-869B-932AE43A66B9Q36942165-67595C96-89A9-4275-993F-56CF241BC81FQ37226877-681D2D44-52C2-42C9-ABAF-0B1755786CDAQ37261091-C8CEF8CC-4852-4239-9483-A1A377EB0883Q37292239-A37D375D-8DBC-4536-ACB0-DFEA84C30F7FQ37471710-4763DEB5-2BDF-4833-B986-AAB8857C80B7Q37862878-DCF0209F-6BF8-431C-9F27-C56CD400675DQ38005896-446F1206-190D-4F54-B79E-563404B2199BQ38018268-CBDD0D4D-F8B7-40FC-8F97-64FFE34673F4Q40576547-B84DEE01-5545-4F17-A32F-C1A2EA57601CQ44621765-33055447-0368-4CB4-A5D3-E6429474EB1DQ46832065-1FA7B619-9916-4F41-82E5-02606B054640Q47355415-B204CB0F-64FD-44A9-8C23-99F83F0FD99DQ47369482-D969415E-4834-4F94-A1E9-D50B2802DF6BQ47843412-C3DFFE79-6AE1-4B83-A031-DA5B5AE305ACQ51352550-C31D06DA-20AD-4723-954F-D3B1C184842EQ53671354-918DD45A-6E6E-4060-ACC0-F8075F3FCD7C
P2860
Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Circulating peptide YY, weight ...... ry in morbidly obese subjects.
@en
Circulating peptide YY, weight ...... ry in morbidly obese subjects.
@nl
type
label
Circulating peptide YY, weight ...... ry in morbidly obese subjects.
@en
Circulating peptide YY, weight ...... ry in morbidly obese subjects.
@nl
prefLabel
Circulating peptide YY, weight ...... ry in morbidly obese subjects.
@en
Circulating peptide YY, weight ...... ry in morbidly obese subjects.
@nl
P2093
P1433
P1476
Circulating peptide YY, weight ...... ry in morbidly obese subjects.
@en
P2093
Antonio M Lacy
Josep Vidal
Ramon Gomis
Rosa Morínigo
Roser Casamitjana
Salvadora Delgado
P304
P356
10.1097/SLA.0B013E31815F6E77
P407
P577
2008-02-01T00:00:00Z